Commodity	Region/Indoor (a)	Residue levels observed in the supervised residue trials (mg/kg)	Comments/Source	Calculated MRL (mg/kg)	HR (b) (mg/kg)	STMR (c) (mg/kg)	CF (d)
RD‐Mo and RD‐RA1: thiabendazole
Apples	Indoor (post‐harvest)	Mo: Dipping at 110 g a.s./hL: 1.5; 1.6; 1.7; 1.7; 1.7; 1.7; 1.9; 2.0 Dipping at 120 g a.s./hL: 2.1; 2.3; 2.5; 3.0	8 trials on apples with dipping at 110 g a.i./hL and 4 trials on apples with dipping at 120 g a.i./hL (EFSA, 2016).	4	3.0	1.80	n.r.
Potatoes	NEU (seed treatment)	< 0.01; < 0.01; < 0.01; < 0.01; < 0.01; 0.01; 0.02; 0.02	Residue trials on potatoes compliant with GAP (EFSA, 2016).	0.04	0.02	< 0.01	n.r.
	SEU (seed treatment)	< 0.01; < 0.01; < 0.01; < 0.01; < 0.01; < 0.01; < 0.01; 0.02	Residue trials on potatoes compliant with GAP (EFSA, 2016).	0.03	0.02	< 0.01	n.r.
Avocadoes	Import tolerance (post‐harvest)	243–250 g a.s./hL: 1.32; 2.4; 2.41, 2.6, 2.71, 3.4, 3.55, 4.5 (whole fruits) [0.08; 0.027; 0.05; 0.023; 0.16; 0.010, 0.03; 0.012 (pulp)]	Residue trials on mangoes compliant with GAP on avocados considering the 25% tolerance (Spain, 2021; EFSA, 2021).	7	4.5 [pulp: 0.16]	2.66 [pulp: 0.03]	n.r.
		194 g a.s./hL: 1.04, 1.07, 2.39, 2.75 [2 × 0.04, 2 × 0.07 (pulp)]	Residue trials on mangoes compliant with GAP on avocados considering the 25% tolerance (Spain, 2021).	6	2.75 [pulp: 0.07]	1.73 [pulp: 0.055]	n.r.
RD‐RA2: total benzimidazole
Apples	Indoor (post‐harvest)	–	Not relevant for post‐harvest GAP.	n.r.	n.r.	n.r.	n.r.
Potatoes	NEU (seed treatment)	4 × < 0.01	Residue trials on potatoes compliant with GAP and analysing for benzimidazole and its conjugates (Spain, 2021).	n.r.	< 0.01	< 0.01	n.r.
	SEU (seed treatment)	4 × < 0.01		n.r.	< 0.01	< 0.01	n.r.
Avocadoes	Import tolerance (post‐harvest)	243–250 g a.s./hL: 4 × < 0.01	Not relevant for post‐harvest GAP but 8 available trials confirm the absence of benzimidazole (Spain, 2021).	n.r.	n.r.	n.r.	n.r.
		194 g a.s./hL: 4 × < 0.01		n.r.	n.r.	n.r.	n.r.

MRL: maximum residue level; GAP: Good Agricultural Practice; Mo: monitoring; RA: risk assessment.

^*Indicates that the MRL is proposed at the limit of quantification.

n.r.: not relevant (benzimidazole is not considered relevant for enforcement purposes).

In bold the values considered within the risk assessment.

^(a)NEU: Outdoor trials conducted in northern Europe, SEU: Outdoor trials conducted in southern Europe, Indoor: indoor EU trials or Country code: if non‐EU trials.

^(b)Highest residue. The highest residue for risk assessment refers to the whole commodity and not to the edible portion.

^(c)Supervised trials median residue. The median residue for risk assessment refers to the whole commodity and not to the edible portion.

^(d)Supervised trials median residue according to the residue definition for monitoring.

^(e)Conversion factor to recalculate residues according to the residue definition for monitoring to the residue definition for risk assessment.